Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2002 Jul 09;9914:9456-61. doi: 10.1073/pnas.142302299.
Show Gene links
Show Anatomy links
Chimeric snRNA molecules carrying antisense sequences against the splice junctions of exon 51 of the dystrophin pre-mRNA induce exon skipping and restoration of a dystrophin synthesis in Delta 48-50 DMD cells.
De Angelis FG
,
Sthandier O
,
Berarducci B
,
Toso S
,
Galluzzi G
,
Ricci E
,
Cossu G
,
Bozzoni I
.
???displayArticle.abstract???
Deletions and point mutations in the dystrophin gene cause either the severe progressive myopathy Duchenne muscular dystrophy (DMD) or the milder Becker muscular dystrophy, depending on whether the translational reading frame is lost or maintained. Because internal in-frame deletions in the protein produce only mild myopathic symptoms, it should be possible, by preventing the inclusion of specific mutated exon(s) in the mature dystrophin mRNA, to restore a partially corrected phenotype. Such control has been previously accomplished by the use of synthetic oligonucleotides; nevertheless, a significant drawback to this approach is caused by the fact that oligonucleotides would require periodic administrations. To circumvent this problem, we have produced several constructs able to express in vivo, in a stable fashion, large amounts of chimeric RNAs containing antisense sequences. In this paper we show that antisense molecules against exon 51 splice junctions are able to direct skipping of this exon in the human DMD deletion 48-50 and to rescue dystrophin synthesis. We also show that the highest skipping activity was found when antisense constructs against the 5' and 3' splice sites are coexpressed in the same cell.
Anderson,
Multiplex Western blotting system for the analysis of muscular dystrophy proteins.
1999, Pubmed
Anderson,
Multiplex Western blotting system for the analysis of muscular dystrophy proteins.
1999,
Pubmed
Berghella,
Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene.
1999,
Pubmed
Bertrand,
The expression cassette determines the functional activity of ribozymes in mammalian cells by controlling their intracellular localization.
1997,
Pubmed
Bond,
Multiple processing-defective mutations in a mammalian histone pre-mRNA are suppressed by compensatory changes in U7 RNA both in vivo and in vitro.
1991,
Pubmed
Buonomo,
The Rev protein is able to transport to the cytoplasm small nucleolar RNAs containing a Rev binding element.
1999,
Pubmed
,
Xenbase
Campeau,
Transfection of large plasmids in primary human myoblasts.
2001,
Pubmed
Cech,
RNA as an enzyme.
1989,
Pubmed
Chen,
Persistence in muscle of an adenoviral vector that lacks all viral genes.
1997,
Pubmed
Cho,
Modulation of Starling forces and muscle fiber maturity permits adenovirus-mediated gene transfer to adult dystrophic (mdx) mice by the intravascular route.
2000,
Pubmed
Crooke,
Molecular mechanisms of antisense drugs: RNase H.
1998,
Pubmed
Datta,
Genetic evidence for base pairing between U2 and U6 snRNA in mammalian mRNA splicing.
1991,
Pubmed
Dunckley,
Modification of splicing in the dystrophin gene in cultured Mdx muscle cells by antisense oligoribonucleotides.
1998,
Pubmed
Fragapane,
Identification of the sequences responsible for the splicing phenotype of the regulatory intron of the L1 ribosomal protein gene of Xenopus laevis.
1992,
Pubmed
,
Xenbase
Galli,
Biochemical complementation with RNA in the Xenopus oocyte: a small RNA is required for the generation of 3' histone mRNA termini.
1983,
Pubmed
,
Xenbase
Gorman,
Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.
1998,
Pubmed
Gorman,
Restoration of correct splicing of thalassemic beta-globin pre-mRNA by modified U1 snRNAs.
2000,
Pubmed
Grimm,
The low abundance of U7 snRNA is partly determined by its Sm binding site.
1993,
Pubmed
,
Xenbase
Gussoni,
The fate of individual myoblasts after transplantation into muscles of DMD patients.
1997,
Pubmed
Hodgson,
Carrier detection and prenatal diagnosis in Duchenne and Becker muscular dystrophy.
1989,
Pubmed
Koenig,
The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion.
1989,
Pubmed
Kole,
Antisense effects in the cell nucleus: modification of splicing.
2001,
Pubmed
Mann,
Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse.
2001,
Pubmed
Michienzi,
U1 small nuclear RNA chimeric ribozymes with substrate specificity for the Rev pre-mRNA of human immunodeficiency virus.
1996,
Pubmed
,
Xenbase
Michienzi,
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.
2000,
Pubmed
Morgenstern,
Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line.
1990,
Pubmed
Partridge,
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts.
1989,
Pubmed
Sierakowska,
Repair of thalassemic human beta-globin mRNA in mammalian cells by antisense oligonucleotides.
1996,
Pubmed
Spycher,
3' end processing of mouse histone pre-mRNA: evidence for additional base-pairing between U7 snRNA and pre-mRNA.
1994,
Pubmed
,
Xenbase
Sullenger,
Tethering ribozymes to a retroviral packaging signal for destruction of viral RNA.
1993,
Pubmed
Sun,
A novel U2-U6 snRNA structure is necessary for mammalian mRNA splicing.
1995,
Pubmed
Suter,
Double-target antisense U7 snRNAs promote efficient skipping of an aberrant exon in three human beta-thalassemic mutations.
1999,
Pubmed
van Deutekom,
Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells.
2001,
Pubmed
Wang,
Adeno-associated virus vector carrying human minidystrophin genes effectively ameliorates muscular dystrophy in mdx mouse model.
2000,
Pubmed
Wilton,
Specific removal of the nonsense mutation from the mdx dystrophin mRNA using antisense oligonucleotides.
1999,
Pubmed
Yuo,
Sequences required for 3' end formation of human U2 small nuclear RNA.
1985,
Pubmed
,
Xenbase
Zatz,
Frequency of Duchenne muscular dystrophy carriers.
1977,
Pubmed
Zhuang,
A compensatory base change in U1 snRNA suppresses a 5' splice site mutation.
1986,
Pubmed
